secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGENUS INC (AGEN)
CIK:        0001098972
Form:       8-K
Filed at:   2024-02-15T23:59:59+00:00
Accession:  0000950170-24-015604
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Agenus proposes 1-for-20 reverse stock split to regain Nasdaq $1 compliance
---------------------------------------------------------------------------

- Reverse stock split at 1:20 ratio proposed to lift share price above $1 Nasdaq minimum.
- Special shareholder meeting set for April 3, 2024 to vote on the split.
- Company plans BLA submission for metastatic colorectal cancer with potential 2025 launch.
- Also exploring monetization of royalty assets and real estate to strengthen finances.
- Engaged in discussions with pharmaceutical companies for potential cash infusions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1098972/000095017024015604/0000950170-24-015604-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1098972/000095017024015604/agen-20240215.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-015604

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer